LAS VEGAS, Aug. 3, 2011 /PRNewswire/ -- Grupo International,
Inc., (OTC/Pink Sheets: trading symbol "GRPI") President
Ramon Richard announced today that
the Company has posted with the Securities and Exchange Commission
its most recent 10K and 10Q filing and should complete any
additional filings within the next two weeks. At that time, the
Company will be in full compliance with all reporting necessary
requirements to reapply for listing back on the Bulletin Board.
President Ramon Richard stated
that the audits and filings were necessary in order to complete the
Company's most recent acquisition of 80% of the Grupo Richard &
Lange operations. The Company expects that the acquisition asset
value of $5,000,000 should be in line
with expectations. The audit of the acquisition is scheduled to be
completed by the end of August. The Company then plans to give some
guidance as to the earnings expected from these operations as well
as its plans for the future direction of its medical research
division. Descriptions of the Richard and Lange operations can be
found on the Company's web site "www.grupointl.com".
Any questions can be addressed to Investor Relations at
telephone 702- 952-3998 or emailed to IR@grupointl.com .
Safe Harbor:
The information contained in this press release, including any
"forward looking" statements within the meaning of section 27A of
the securities Act of 1993 and Section 21E of the Securities
Exchange Act of 1934 contained herein, should be reviewed in
conjunction with the Company's Annual Report on Form 10-KSB and
other publicly available information regarding the Company, copies
of which are available from the Company upon request. Such publicly
available information sets forth many risks and uncertainties
related to the Company's business and such statements, including
risks and uncertainties related to that are unpredictable and
outside of the influence and/or control of the Company. In
particular, these risks and uncertainties include, without
limitation: that third parties may be successful in challenging the
patent issued; that granted claims may be held invalid or
interpreted differently by a court of law; that other patents will
issue that will block the Company from commercializing the
technology covered by the patents; and that the benefits that
Company believes can be derived from the patented technology will
not be realized due to difficulties encountered in the long and
expensive process of the development of new technologies and the
cost and uncertainty in obtaining regulatory approval for products
based on these technologies. In addition, there are many other
risks and uncertainties inherent in the development of the
Company's products, including the risk of not obtaining regulatory
approval for a variety of reasons and the risk of adverse side
effects in humans. Other risks relating to Company are detailed
from time to time in documents filed by Company with the SEC.
CONTACT:
Grupo International Inc.
Investors Relations:
Email: IR@grupointl.com
702-952-3998
SOURCE Grupo International, Inc.
